Introduction
The tissues of the lung alone receive virtually the entire venous circulating blood volume coming from other organs of the body. It is not therefore surprising that the lungs are affected in a wide variety of multisystem disorders. In particular it is not suprising that an inflammatory response and fibrotic reaction in the lung is common to several different connective tissue syndromes including systemic lupus erythematosus (SLE), rheumatoid arthritis and systemic sclerosis as well as occurring occasionally in a number of other conditions such as primary biliary cirrhosis, chronic active hepatitis, ulcerative colitis, Sj6gren's syndrome, autoimmune thyroiditis and ill defined digital vasculitides. A central unresolved question is why lung involvement is very common in certain syndromes such as systemic sclerosis and apparently very much less common in others such as ulcerative colitis and perhaps chronic hepatic disease. Another unexplained fact is that a number of different types of pathology may be found in the lungs of different patients with the same connective tissue syndrome (Table I ). For example, in rheumatoid arthritis, In passing, it should be noted that in this series extractable nuclear antigen (ENA) was found in association with a variety of clinical syndromes and the clinical features of 'mixed connective tissue disease', as described by Sharpe and colleagues3 was found in only two patients. As expected rheumatoid factor is raised more frequently and found in higher titres in those with associated disorders because this group includes all patients with rheumatoid arthritis. However, raised titres of rheumatoid factor are found more frequently in patients with 'lone' CFA compared with normal controls.I0
Circulating immune complexes are commonly found in CFA but the prevalence as well as the titres are often higher in those with associated disorders (Figure 2 ). Probably associated with this, antibody-dependent lymphocyte cytoxicity shows greater impairment in CFA with associated disorders than in those with 'lone' disease. When fibrosing alveolitis is also present, deposits of immune complexes in the pulmonary capillaries have been shown occasionally both in SLE where complement can also be found ( Figure 3 ) and in rheumatoid arthritis where it is sometimes absent.5 6 Deposits in the media of larger pulmonary arteries are very occasionally seen (Figure 4 ).7 Electron microscopic evidence of immune complexes is almost always negative although occasionally tubular reticular structures as previously described by Yeo and colleagues8 are found ( Figure   5 ).
The fact that when CFA with and without associated disorders are compared, several immunological features differ (at least in intensity) while the clinical features are similar, suggests that these immunological markers may have relatively little influence on the pathogenesis of disease in the lung.
Pathogenesis
To explain the similar as well as distinctive pathologies found in the lungs in different connective tissue disorders, we have explored the hypothesis represented schematically in Figure 6 . In this it is suggested that the type of lesion found is at least in part due to the size of the pulmonary vessels bearing the brunt of damage as well as the modulating influence of the secondary circulation of the lung (bronchial circulation), 'protecting' tissue oxygenation. The larger the vessels affected the greater the chances of ischaemic necrosis or infarction. Microscopic areas of increased metabolism due to concomitant inflammatory infiltrates may be particularly vulnerable.
The hypothesis goes some way to explain why a similar pathological process in the lung may be found in a range of disorders limited to the lung, such as 'lone' CFA, pulmonary hypertension, idiopathic pulmonary haemosiderosis (IPH) and haemorrhage or veno-occlusive disease. It may also explain why an identical pathology is also found in the lungs of patients with a variety of associated connective tissue disorders. For example CFA, pulmonary hypertension and a pulmonary haemosiderosis and haemorrhage have also all been found in patients with SLE. Evidence supporting the importance of pulmonary capillary damage in fibrosing alveolitis with and without associated connective tissue disease is to be found in the marked increase in lung permeability measurements observed in these conditions ( Figure 7 ). Permeability is even more rapid in cases of IPH and pulmonary haemorrhage where evidence for pulmonary endothelial damage on electron microscopy has been reported.9
Alveolitis is also found in 'hypersensitivity' drug reactions and these too may affect other systems commonly involved in connective tissue disorders including joints, serosal surfaces, skin including digital vasculitis, eyes and kidneys. The 
